The Diagnosis and Treatment of Crohn's Disease and Ulcerative Colitis
Author:
Publisher
Deutscher Arzte-Verlag GmbH
Subject
General Medicine
Reference25 articles.
1. Baumgart DC, Sandborn WJ: Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007; 369:1641–57.
2. Baumgart DC, Carding SR: Inflammatory bowel disease: cause and immunobiology. Lancet 2007; 369: 1627–40.
3. Xavier RJ, Podolsky DK: Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007; 448: 427–34.
4. Stange EF, Travis SP, Vermeire S, Beglinger C, Kupcinkas L, Geboes K, et al.: European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut 2006; 55 Suppl 1: i1–15.
5. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR et al.: Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19 Suppl A: 5–36.
Cited by 71 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Yangısal hastalıklarda hiperbarik oksijen tedavisi;Troia Medical Journal;2024-01-07
2. The Role of Serological Markers in the Prediction of Disease Course and Response to Therapy in Inflammatory Bowel Disease;Cureus;2023-11-07
3. Real-World Effectiveness of Vedolizumab vs Anti-TNF in Biologic-naïve Crohn’s Disease Patients: A 2-year Propensity-score-adjusted Analysis from the VEDOIBD-Study;Inflammatory Bowel Diseases;2023-07-31
4. Real‐world effectiveness of vedolizumab compared to anti‐TNF agents in biologic‐naïve patients with ulcerative colitis: A two‐year propensity‐score‐adjusted analysis from the prospective, observational VEDOIBD‐study;Alimentary Pharmacology & Therapeutics;2023-06-15
5. Novel treatment of acute and acute‐on‐chronic liver failure: Interleukin‐22;Liver International;2023-05-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3